Rocco Capuano

3.5k total citations
30 papers, 410 citations indexed

About

Rocco Capuano is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Oncology. According to data from OpenAlex, Rocco Capuano has authored 30 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 8 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in Rocco Capuano's work include Multiple Sclerosis Research Studies (20 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Peripheral Neuropathies and Disorders (5 papers). Rocco Capuano is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Peripheral Neuropathies and Disorders (5 papers). Rocco Capuano collaborates with scholars based in Italy, United States and Spain. Rocco Capuano's co-authors include Gioacchino Tedeschi, Antonio Gallo, Alvino Bisecco, Alessandro d’Ambrosio, Manuela Altieri, Renato Docimo, Simona Bonavita, Gabriella Santangelo, Giuseppina Caiazzo and Mario Cirillo and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Journal of Neurology.

In The Last Decade

Rocco Capuano

30 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rocco Capuano Italy 14 237 100 88 49 43 30 410
Wendy Vargas United States 13 186 0.8× 178 1.8× 140 1.6× 18 0.4× 24 0.6× 35 498
William Rowles United States 13 250 1.1× 89 0.9× 110 1.3× 30 0.6× 9 0.2× 28 437
Boulenouar Mesraoua Qatar 14 162 0.7× 108 1.1× 24 0.3× 40 0.8× 25 0.6× 56 654
RHB Benedict United States 9 341 1.4× 122 1.2× 30 0.3× 31 0.6× 27 0.6× 14 514
Rod Middleton United Kingdom 15 543 2.3× 129 1.3× 44 0.5× 12 0.2× 52 1.2× 54 701
Ian Pomeroy United Kingdom 8 136 0.6× 45 0.5× 72 0.8× 12 0.2× 17 0.4× 12 415
Ahmed Z. Obeidat United States 12 119 0.5× 133 1.3× 19 0.2× 16 0.3× 15 0.3× 45 383
Saurabh Kataria United States 13 91 0.4× 325 3.3× 218 2.5× 13 0.3× 38 0.9× 50 565
André Palma da Cunha Matta Brazil 13 142 0.6× 88 0.9× 34 0.4× 24 0.5× 7 0.2× 33 337
Ulrich Seidel Germany 13 117 0.5× 78 0.8× 25 0.3× 24 0.5× 33 0.8× 28 693

Countries citing papers authored by Rocco Capuano

Since Specialization
Citations

This map shows the geographic impact of Rocco Capuano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Capuano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Capuano more than expected).

Fields of papers citing papers by Rocco Capuano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco Capuano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Capuano. The network helps show where Rocco Capuano may publish in the future.

Co-authorship network of co-authors of Rocco Capuano

This figure shows the co-authorship network connecting the top 25 collaborators of Rocco Capuano. A scholar is included among the top collaborators of Rocco Capuano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco Capuano. Rocco Capuano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altieri, Manuela, Rocco Capuano, Giovanna Donnarumma, et al.. (2023). Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence. Neurological Sciences. 44(11). 4107–4110. 1 indexed citations
2.
Altieri, Manuela, Rocco Capuano, Giovanna Donnarumma, et al.. (2022). Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab. Neurological Sciences. 43(5). 2947–2949. 5 indexed citations
3.
Capuano, Rocco, Manuela Altieri, Alvino Bisecco, et al.. (2022). Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod. Journal of Neurology. 269(12). 6185–6192. 14 indexed citations
4.
Capuano, Rocco, Alvino Bisecco, Giovanna Donnarumma, et al.. (2022). Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod. Multiple Sclerosis and Related Disorders. 60. 103724–103724. 16 indexed citations
5.
Altieri, Manuela, Rocco Capuano, Alvino Bisecco, et al.. (2022). The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis. Multiple Sclerosis and Related Disorders. 61. 103774–103774. 17 indexed citations
6.
Capuano, Eduardo, et al.. (2021). The Burden of Cardio-Cerebrovascular Risk Factors: Differences Between Individual Risk and Population Risk. High Blood Pressure & Cardiovascular Prevention. 28(6). 597–603. 3 indexed citations
7.
Capuano, Rocco, Eduardo Capuano, Anna Iannone, et al.. (2021). Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population. Journal of Nutrition and Metabolism. 2021. 1–8. 4 indexed citations
8.
Gallo, Antonio, Rocco Capuano, Giovanna Donnarumma, et al.. (2021). Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab. Neurological Sciences. 42(9). 3523–3526. 31 indexed citations
9.
Capuano, Rocco, Giovanna Donnarumma, Alvino Bisecco, et al.. (2021). Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab. Therapeutic Advances in Neurological Disorders. 14. 4203319199–4203319199. 15 indexed citations
10.
Capuano, Rocco, Manuela Altieri, Alvino Bisecco, et al.. (2020). Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?. Journal of Neurology. 268(3). 743–750. 59 indexed citations
11.
Bisecco, Alvino, Manuela Altieri, Gabriella Santangelo, et al.. (2020). Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study. Frontiers in Behavioral Neuroscience. 13. 276–276. 17 indexed citations
12.
Capuano, Rocco, Settimio Rossi, Alvino Bisecco, et al.. (2020). Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod. Neurological Sciences. 42(2). 731–733. 4 indexed citations
13.
Liparoti, Marianna, Marida Della Corte, Rosaria Rucco, et al.. (2019). Gait abnormalities in minimally disabled people with Multiple Sclerosis: A 3D-motion analysis study. Multiple Sclerosis and Related Disorders. 29. 100–107. 38 indexed citations
14.
Lavorgna, Luigi, Sabrina Esposito, Roberta Lanzillo, et al.. (2019). Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey. Journal of Neurology. 266(3). 707–716. 14 indexed citations
15.
Bisecco, Alvino, Gabriella Santangelo, Luigi Trojano, et al.. (2018). Cognitive impairment in Multiple Sclerosis: the contribution of cognitive reserve and regional gray matter volumes (P3.365). Neurology. 90(15_supplement). 1 indexed citations
16.
Todisco, Vincenzo, et al.. (2018). Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome. Clinical Neurophysiology Practice. 3. 148–150. 6 indexed citations
17.
Lavorgna, Luigi, Giovanna Borriello, Sabrina Esposito, et al.. (2018). Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. Multiple Sclerosis and Related Disorders. 27. 239–246. 10 indexed citations
18.
Capuano, Vincenzo, et al.. (2016). Hyperuricemia as an independent risk factor for major cardiovascular events. Journal of Cardiovascular Medicine. 18(3). 159–164. 25 indexed citations
19.
Capuano, Vincenzo, et al.. (2015). Ten year cardio-cerebro-vascular mortality and morbidity in a Southern Italy cohort: the VIP Project data. Monaldi Archives for Chest Disease. 80(1). 31–4. 2 indexed citations
20.
Capuano, Eduardo, et al.. (2013). The safety of statins in children. Acta Paediatrica. 102(9). 857–862. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Vargas Breakdown of academic impact, for papers by William Rowles Breakdown of academic impact, for papers by Boulenouar Mesraoua Breakdown of academic impact, for papers by RHB Benedict Breakdown of academic impact, for papers by Rod Middleton Breakdown of academic impact, for papers by Ian Pomeroy Breakdown of academic impact, for papers by Ahmed Z. Obeidat Breakdown of academic impact, for papers by Saurabh Kataria Breakdown of academic impact, for papers by André Palma da Cunha Matta Breakdown of academic impact, for papers by Ulrich Seidel
Rankless by CCL
2026